Skip to content 
Our services are focused on the commitment to providing a better life for all people. Our array of products, how we manufacture them, and how we interact with society – preserve our mantra.
We are fully invested in promoting a better life for all people, and this reflects in the way we manufacture and present our affordable products.
Keep up to date with our news and recent announcements
We believe that our business endeavors should have a positive effect on the environment and society as a whole.
According to the Federal Ministry of Health, Nigeria suffers the world’s greatest malaria burden, with approximately 51 million cases and 207,000 deaths reported annually.
Fidson Healthcare Plc has assured that the company would build on its impressive historic growth and provide investors with good returns in the years ahead.
For nearly 25 years, Fidson Healthcare Plc is relentlessly pursuing its goal of becoming the dominant player in the pharmaceutical sector in Nigeria. It has
Fidson Healthcare Plc recently released its 2018 audited financial report to the Nigerian Stock Exchange, reporting a 15% growth in turnover from N14.06bn in 2017
“I Thought He Would Die — Mother of congenital heart defect Patient” Mr. and Mrs. Omobowale, parents of baby Israel who was diagnosed with congenital
The company’s effort in the area of Children’s education can also not go without mentioning. Fidson started its CSR programme with the Children Emergency Relief
Lagos State government has commended Fidson Healthcare Plc for its relentless commitment to the academic development of Nigerian children through the company’s ASTYMIN brand annual
Also, at another recent event, Fidson yet again reaffirmed its commitment to support another set of children with Down Syndrome as part of its CSRprogramme.
The Pharmaceutical Society of Nigeria (PSN) has commended Fidson Healthcare on giant strides the company is making in local manufacturing of essential medicines. President PSN,
Fidson Healthcare Plc’s organic expansion into new products category has delivered sustainable earnings growth for the company. The drug maker continues to utilize the resources
268, Ikorodu Road, Obanikoro P. O. Box 7210, Shomolu, Lagos, Nigeria
Optimized by Seraphinite Accelerator